Abstract

Abstract Aleutian disease (AD) is an untreatable immune complex disease in mink and brings tremendous economic losses to the mink industry globally. The ineffectiveness of culling, immunoprophylaxis, and medical treatment in controlling AD have urged mink farmers to select AD-resilient mink based on the AD tests. However, the genetic analysis of these tests and their correlations with AD-resilient traits have not been investigated. In this study, data on 5,824 mink were used to estimate the genetic and phenotypic parameters of four AD tests, including two systems of enzyme-linked immunosorbent assay (ELISA), counterimmunoelectrophoresis (CIEP), and iodine agglutination test (IAT), and their genetic and phenotypic correlations with pelt quality, reproductive performance, packed-cell volume (PCV), and harvest length (HL). Significance (P < 0.05) of fixed effects (sex, year, color type, the number of mating, and dam age), covariates (age at blood sampling and age at harvest), and random effects (additive genetic, permanent environmental, and maternal effects) were determined using univariate models. The genetic and phenotypic parameters for all traits were estimated under bivariate models using ASReml 4.1. Estimated heritabilities (±SE) were 0.39±0.05, 0.61±0.07, 0.11±0.07, and 0.26±0.05 for antigen-based ELISA (ELISA-G), virus capsid protein-based ELISA, CIEP, and IAT, respectively. The ELISA-G showed moderate repeatability (0.58±0.04) and significant (P < 0.05) negative genetic correlations (±SE) with reproductive performance traits (from -0.41±0.16 to -0.49±0.12), PCV (-0.53±0.09), and HL (-0.45±0.16). These results indicated that the selection of mink with a lower ELISA-G score could not only decrease the anti-AMDV antibody level and the extent of anemia but also improve the female reproductive performance and the harvest length of mink without causing adverse influences on the pelt quality. Hence, ELISA-G could be applied as an indicator for genetic selection of AD-resilient mink and help mink farmers reduce the adverse effects of AD.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call